The final phase of the trial is currently underway. However, it will end by the end of this year. Meanwhile, Regeneron Pharmaceuticals has claimed its effectiveness based on the information obtained from the trial.
Although no final results have been obtained, the company claims that the drug will be able to break the chain of coronary infections. Regeneration President George Yankopoulos said that despite the introduction of vaccine programs around the world, millions of people are still infected with the coronavirus every day. They continue to actively infect people close to them. Resin-cove drugs are able to break this chain. These drugs are able to cause instant passive immunity in those at high risk of infection. On the other hand, it takes a few weeks for the vaccine to become effective.
Regeneron analyzed the results of a test run on 400 volunteers. One or another member of their family is affected by corona. This drug is a cocktail or combination of two antibodies. It protects the body from the SARS-Cov-2 virus. The drug was also given to former US President Donald Trump after he was infected with the coronavirus. He claimed that this medicine had healed him.
This drug should be applied to those who need immediate protection from corona. People who have had contact with someone who has had coronary artery disease, or who have had coronary heart disease, or who have had coronary heart disease should take this medicine. It is currently being tested in Britain under the auspices of Oxford University. More than 2,000 patients are being monitored in 164 hospitals across the country.